In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to ACCA Ivory (& above) Members, Fellows of the ESC and Young combined Members

Patients with non obstructive coronary artery disease admitted with acute coronary syndrome carry a better outcome compared to those with obstructive coronary artery disease

Session Poster Session 4

Speaker Assistant Professor Adel Bakr

Congress : Acute Cardiovascular Care 2015

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Non-ST-Elevation Myocardial Infarction (NSTEMI)
  • Session type : Poster Session
  • FP Number : P615

Authors : Y Yazeed (Cairo,EG), A Bakr (Cairo,EG), M M Abdelghany (Cairo,EG)

15 views

Authors:
Y Yazeed1 , A Bakr1 , M M Abdelghany1 , 1Cairo University Hospitals, Department of Cardiovascular Medicine - Cairo - Egypt ,

Citation:
European Heart Journal: Acute Cardiovascular Care ( 2015 ) 4 ( Supplement 5 ), S257

Background: The characterization of patients who have acute coronary syndrome (ACS) with insignificant coronary stenosis is unclear.
Aim: The present study aimed to investigate the clinical profile, in-hospital and 3-months outcome of ACS patients with insignificant coronary stenosis on a coronary angiography.
Methods: This prospective observational study included 200 consecutive patients admitted with ACS. Group I (100 patients) included patients with insignificant CAD (all lesions <50% stenosis). Group II (100 patients) included patients with one or more lesions ? 70% stenosis. Patients with Previous CABG were excluded.
Results: Patients with insignificant CAD were significantly younger (61 vs. 67 years, p <0.001), more likely to be females (41% vs. 23%, p = 0.006), less likely to smoke (p = 0.006), less likely to have diabetes mellitus (p <0.001), and less likely to have history of CAD (p = 0.042 ) or prior PCI (p = 0.037). They were also less likely to have typical anginal pain at presentation (61% vs 91%, p<0.001), less likely to have heart failure at presentation (9% vs 30%, p<0.001), less likely to have ischemic ST-segment changes on presentation, (10% vs 46%, p <0.001), lower peak troponin (p <0.001) and CK-MB levels (p <0.001), with lower LDL-C (p = 0.006), and higher HDL-C level (p = 0.020). they were less likely to be treated with thienopyridines (p <0.001), statins (p<0.001), b-blockers (p = 0.002), ACEI/ARBS (p = 0.007), and higher rates of calcium channel blocker therapy (p <0.001). They had lower prevalence of major adverse clinical events at follow up (readmission for ACS (p = 0.009), revascularization (p = 0.035), recurrent chest pain (p = 0.009), cardiogenic shock (p = 0.029).
Conclusion: Patients with ACS and insignificant CAD have different clinical profile and outcome compared to those with significant disease.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are